The clinical importance of HIF-1α expression in prostate cancer has been demonstrated and HIF-1α has been examined as a potential prognostic marker, being elevated in high grade PIN and not BPH [54]. The gene discussed is HIF1A; the disease is benign prostatic hyperplasia.